Provectus Biopharmaceuticals Inc PVCT:OTCQB

*Data is delayed | Exchange | USD
Last | 03/28/24 EDT
0.1829quote price arrow down-0.0171 (-8.575%)
Volume
236,436
52 week range
0.06 - 0.22
Loading...
  • Open0.20
  • Day High0.20
  • Day Low0.1771
  • Prev Close0.20
  • 52 Week High0.22
  • 52 Week High Date03/18/24
  • 52 Week Low0.06
  • 52 Week Low Date10/18/23

Key Stats

  • Market Cap76.71M
  • Shares Out419.52M
  • 10 Day Average Volume309,505.9
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change90.47

KEY STATS

  • Open0.20
  • Day High0.20
  • Day Low0.1771
  • Prev Close0.20
  • 52 Week High0.22
  • 52 Week High Date03/18/24
  • 52 Week Low0.06
  • 52 Week Low Date10/18/23
  • Market Cap76.71M
  • Shares Out419.52M
  • 10 Day Average Volume309,505.9
  • Dividend-
  • Dividend Yield-
  • Beta0.65
  • YTD % Change90.47

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-32.72
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-2.475M
  • ROE (TTM)-934.31%
  • Revenue (TTM)601,440.012
  • Gross Margin (TTM)-
  • Net Margin (TTM)-527.23%
  • Debt To Equity (MRQ)-40.84%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Provectus Biopharmaceuticals Inc

 

Profile

MORE
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform comprises a range of different drug product candidates and preclinical pharmaceutical-grade...
Edward Pershing CPA
Non-Executive Independent Chairman of The Board
Dominic Rodrigues
Principal Executive Officer, Vice Chairman of the Board
Heather Raines CPA
Chief Financial Officer
Eric Wachter Ph.D.
Chief Technology Officer
Address
800 S. Gay Street, Suite 1610
Knoxville, TN
37929
United States

Top Peers

SYMBOLLASTCHG%CHG
CYTH
Cyclo Therapeutics Inc
1.39UNCHUNCH
VYNE
Vyne Therapeutics Inc
3.07UNCHUNCH
KALA
KALA BIO Inc
7.84UNCHUNCH
TLPH
Talphera Inc
1.03UNCHUNCH
SEEL
Seelos Therapeutics Inc
0.591UNCHUNCH